Contract X Organizations

Recent Articles

RELATED ARTICLES

  1. This pharma services provider has shocked investors with a steep downward revision of its earnings outlook, slashing its full-year revenue growth forecast to just 10% from an initial 30% and predicting a profit drop.
    WuXi Bio prescribes share buyback to relieve revenue pain
    2269.HK
  2. Potential U.S. targeting casts shadow over WuXi AppTec family
    2359.HK 603259.SHG
  3. FAST NEWS: WuXi Biologics boosts new projects target
    2269.HK
  4. FAST NEWS: WuXi XDC kicks off IPO with star cornerstone investors
    2269.HK
  5. FAST NEWS: WuXi XDC’s profit surges on growth in ADC market
    2268.HK
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo Youtube

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva